ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

KALA KALA BIO Inc

6.83
0.0939 (1.39%)
Última actualización: 13:56:10
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
KALA BIO Inc KALA NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.0939 1.39% 6.83 13:56:10
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
6.81 6.81 7.03 6.7361
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
03/6/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202415:03EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29/5/202407:00GLOBEKALA BIO to Present at Jefferies Global Healthcare..
14/5/202415:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202415:06EDGAR2Form 8-K - Current report
14/5/202415:05GLOBEKALA BIO Reports First Quarter 2024 Financial Results and..
29/3/202407:00GLOBEKALA BIO Reports Fourth Quarter and Full Year 2023 Financial..
04/3/202406:30EDGAR2Form 8-K - Current report
26/2/202407:00GLOBEKALA BIO to Present at TD Cowen 44th Annual Healthcare..
14/2/202412:09EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202407:00GLOBEKALA BIO to Present at Oppenheimer 34th Annual Healthcare..
19/1/202415:01GLOBEKALA BIO Reports Inducement Grants Under Nasdaq Listing Rule..
05/1/202415:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202415:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202415:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202307:22EDGAR2Form 8-K - Current report
13/11/202307:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202307:05EDGAR2Form 8-K - Current report
13/11/202307:00GLOBEKALA BIO Reports Third Quarter 2023 Financial Results and..
18/10/202315:04EDGAR2Form SC 13D/A - General statement of acquisition of..
20/9/202315:01GLOBEKALA BIO Reports Inducement Grants Under Nasdaq Listing Rule..
05/9/202307:00GLOBEKALA BIO to Present at H.C. Wainwright 25th Annual Global..
04/8/202307:00GLOBEKALA BIO Reports Second Quarter 2023 Financial Results and..
02/8/202315:01EDGAR2Form 8-K - Current report
02/8/202315:01GLOBEKALA BIO to Participate in Upcoming Investor Conferences in..
02/8/202307:00GLOBEKala Pharmaceuticals Announces Name Change to KALA BIO
19/7/202315:01GLOBEKala Pharmaceuticals Reports Inducement Grants Under Nasdaq..
23/6/202315:01GLOBEKala Pharmaceuticals Reports Inducement Grants Under Nasdaq..